Breaking News

Tweet TWEET

Cardica to Announce Fiscal 2013 Third Quarter Financial Results On Tuesday, April 30, 2013

 Cardica to Announce Fiscal 2013 Third Quarter Financial Results On Tuesday,
                                April 30, 2013

PR Newswire

REDWOOD CITY, Calif., April 18, 2013

REDWOOD CITY, Calif., April 18, 2013 /PRNewswire/ -- Cardica, Inc. (Nasdaq:
CRDC) today announced that it will release financial results for its fiscal
third quarter ended March 31, 2013, on Tuesday, April 30, 2013, after the
markets close. Cardica's management will host a conference call at 4:30 p.m.
Eastern Time to discuss the financial results and provide an update on the
company's business.

Conference Call Details

To access the live conference call on April 30, 2013, at 4:30 p.m. Eastern
Time via phone, please dial 866-700-6293 from the United States and Canada or
617-213-8835 internationally. The conference ID is 20204428. Please dial in
approximately 10 minutes prior to the start of the call. A telephone replay
will be available beginning approximately two hours after the call through May
7, 2013, and may be accessed by dialing 888-286-8010 from the United States
and Canada or 617-801-6888 internationally. The replay passcode is 73979571.

To access the live and subsequently archived webcast of the conference call,
go to the Investor Relations section of the company's website at
www.cardica.com. Please connect to the website at least 15 minutes prior to
the presentation to allow for any necessary software downloads.

The webcast is also being distributed through the Thomson StreetEvents
Network. Individual investors can listen to the call at www.earnings.com,
Thomson's individual investor portal, powered by StreetEvents. Institutional
investors can access the call via Thomson StreetEvents at
www.streetevents.com, a password-protected event management site.

AboutCardica

Cardicadesigns and manufactures proprietary stapling and anastomotic devices
for cardiac and laparoscopic surgical procedures.Cardica's technology
portfolio is intended to minimize operating time and enable minimally-invasive
and robot-assisted surgeries. Cardica manufactures and markets its automated
anastomosis systems, the C-Port^® Distal Anastomosis Systems and PAS-Port^®
Proximal Anastomosis System for coronary artery bypass graft (CABG) surgery,
and has shipped over 44,100 units throughout the world. In
addition,Cardicais developing the Cardica^® MicroCutter XCHANGE™ 30, a
cartridge-based microcutter device with a five-millimeter shaft diameter and
the Cardica^® MicroCutter XCHANGE™ 45, a cartridge-based microcutter device
with an eight-millimeter shaft. Both MicroCutter devices are designed to be
used in a variety of procedures, including bariatric, colorectal, thoracic and
general surgery. The Cardica MicroCutter XCHANGE 30 and XCHANGE 45 products
require 510(k) review and are not yet commercially available in the U.S.

SOURCE Cardica

Website: http://www.cardica.com
Contact: Bob Newell, Vice President, Finance and Chief Financial Officer,
(650) 331-7133, investors@cardica.com
 
Press spacebar to pause and continue. Press esc to stop.